deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BENITEC BIOPHARMA LIMITED (ASX.BLT)

ASX Announcements (courtesy of ASX)

2011201220132014201520162017201820192020

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
Former (or subsequent) names
CompanyFROMTO
BENITEC BIOPHARMA LIMITED25/11/2011
BENITEC LIMITED30/04/200225/11/2011
QUEENSLAND OPALS NL30/04/2002
Shareholder links
Our website ranking of BLT: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details
ISIN: AU000000BLT8
Address: Level 14, 114 William St Melbourne VIC 3000 Australia
Tel:  +61 (03) 8692-7222 Fax: +61 (03) 9966-9923

Date first listed: 17/02/1997
Company Secretary: Oliver Kidd

Sector: Pharmaceuticals & Biotechnology
Industry Group: XHJ
Activities: Biotechnology, research and development.

delisted from the close of trading on Thursday, 16 April 2020 pursuant to Listing rule 17.11.

16/04/2020

we understand the company changed its domicile from Australia to the United States with Benitec Biopharma Inc acquiring all the shares in BLT and issuing one share in Benitec Biopharma Inc for every 300 BLT shares - Benitec Biopharma Inc will trade on Nasdaq under the symbol BNTC

16/04/2020

The previously announced scheme of arrangement to redomicile from Australia to the United States has been fully implemented today. The redomiciliation was approved by Benitec shareholders at a Scheme Meeting held on 26 March 2020, and approved by the Supreme Court of Queensland on 30 March 2020. Benitec Biopharma is now the sole shareholder in the company and is the ultimate parent company of the group.

15/04/2020

Formal notice was given by the company to NASDAQ on April 2, 2020 (Pacific Time) of the intention to voluntarily delist the company's listed warrants from the NASDAQ Capital Market in connection with the completion of the scheme of arrangement to re-domicile the Benitec group from Australia to the United States of America.

03/04/2020

The Foreign Investment Review Board has now confirmed that the new changes to the foreign investment regime do not apply to agreements entered into prior to 10.30pm (AEDT) on 29 March 2020. As the Company and Benitec Biopharma Inc. entered into the Amended and Restated Scheme Implementation Agreement on 30 January 2020, US Holdco will not be required to notify FIRB in respect of the scheme of arrangement.

31/03/2020

The securities of Benitec Biopharma Limited will be suspended from quotation immediately under Listing Rule 17.2, following lodgement of the Supreme Court of Queensland orders with the Australian Securities and Investments Commission approving the scheme of arrangement by which Benitec Biopharma Inc. will acquire all of the issued shares in BLT.

30/03/2020

we understand that on or about this date the company consolidated its shares 1 for 25

19/07/2013

The suspension of trading in the securities of Benitec Biopharma Limited will be lifted immediately, following receipt of an announcement in relation to the completion of a capital raising.

06/06/2013

The securities of Benitec Biopharma Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, in accordance with listing rule 17.2, pending the release of an announcement by the Company in relation to the completion of a proposed capital raising. Security Code: BLT

05/06/2013

The suspension of trading in the securities of Benitec Biopharma Limited (the "Company") will be lifted immediately, following receipt of an announcement in relation to the completion of a capital raising. Security Code: BLT

05/03/2013

Benitec Biopharma Limited (ASX:BLT) advises that the proposed capital raising is not yet finalised and as a result the voluntary suspension will remain in place pending a further announcement on or before Tuesday 5 March 2013 regarding the outcome of the capital raising.

28/02/2013

The securities of Benitec Biopharma Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, in accordance with listing rule 17.2, pending the release of an announcement by the Company in relation to the completion of a proposed capital raising. Security Code: BLTThe securities of Benitec Biopharma Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, in accordance with listing rule 17.2, pending the release of an announcement by the Company in relation to the completion of a proposed capital raising. Security Code: BLT

27/02/2013

name changed from Benitec Limited

25/11/2011
View ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

What happened to my shares in Benitec after they delisted.??

27/07/2022 17:11:50
Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    27/03/2020Peter Francis875,000$0.031$27,158
    28/05/2018Megan Boston100,000$0.171$17,056
    30/01/2015John ChiplinOn market63,020$0.720$45,500
    05/03/2014Peter FrenchOn market9,939$2.012$19,996

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    Jerel BanksExecutive Chairman26/10/2016
    Peter FrancisNon Exec Chairman08/02/2006
    Cliff HollowayCOO24/08/2016
    Bryan DulhuntyCFO01/07/2016
    Kevin BuchiNon Exec Director11/04/2013
    Megan BostonExecutive Director16/08/2016
    Edward SmithDirector15/04/2020

    Date of first appointment, title may have changed.

    Directors & Executives (former)
    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Greg WestCEO, CFO01/08/201115/06/2018
    John ChiplinNon Exec Director01/02/201023/10/2017
    Iain RossNon Exec Director01/06/201030/09/2016
    Peter FrenchManaging Director, CEO04/06/201009/12/2015
    Melvyn BridgesNon Exec Director12/10/200719/06/2014
    Sue MacLemanCEO04/09/200629/03/2010
    Ken ReedNon Exec Director16/04/2009
    Michael DallingNon Exec Director24/03/200626/02/2008
    Mike CatelaniCFO22/06/2006
    Sara CunninghamExecutive Director18/01/200522/06/2006
    Alexander CappelloNon Exec Director03/02/200517/04/2006
    Raymond WhittenExecutive Chairman28/11/200223/02/2006
    Robert ThomasNon-Executive07/05/200430/11/2005
    John McKinleyNon Exec Director22/04/200215/11/2005
    Gary TaylorCompany Secretary23/07/200201/03/2005
    Michael CoxExecutive Director01/01/199919/12/2003
    James AndersonManaging Director10/09/200230/06/2003
    Graeme WoodrowExecutive Director10/09/200230/06/2003
    John MattickNon Exec Director04/06/200204/10/2002
    Charles FurnessFinance Director22/04/200223/07/2002
    Raymond IacanoNon Exec Director01/06/200004/06/2002
    Rodney AustinNon Exec Director01/01/199622/04/2002
    Peter GrayNon Exec Director01/06/200022/04/2002

    Date of first appointment, title may have changed.